Good Valentine’s Day, traders. Dave here—let’s invent a fresh phrase and get to what actually matters: your portfolio.
Opening Recap
Market Pulse: Markets drift with mixed signals: a Canadian titan’s 25% surge on TSX turns heads, while Bitcoin bulls flirt with new highs as Ether’s open interest tumbles to a three-year low.
Key Movers: Disc Medicine hits a wall with an FDA complete response letter on bitopertin, and TD analysts scramble to revise forecasts upward on TSX gainer; retail shorts on Bitcoin scramble as DOGE eyes $0.10.
Macro & Politics: Inflation eases unexpectedly to 2.4%, nudging closer to the Fed’s target and giving policymakers cover to hold rates longer; Washington’s next move will likely stir headline whiplash.
What’s Next: Eyes on U.S. futures and upcoming CPI whispers—expect choppy trade and rapid shifts as algos hunt profit.
Market Commentary
What everyone’s missing is that regulatory roulette can blow up sectors overnight—see “Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP” (GlobeNewswire). Investors plaster their portfolios with biotech hope, but one damn CRL reminder and bulls wake up with paper losses. The lawsuit chatter around uniQure N.V. underscores that fear, yet most are still chasing headlines instead of digging into FDA readouts to find real value.
Here’s the twist: Ether’s open interest plunging to a three-year low (“ETH open interest falls to 3-year low: What does it mean for Ether price?” – Cointelegraph) and inflation unexpectedly easing to 2.4% (“‘Great news’: Inflation ‘unexpectedly’ ratchets down to 2.4%, closer to Federal Reserve target” – Wnd.com) tell the same story—retail risk appetite is drying up just as the Fed gives itself permission to stay aggressive. If crypto speculators are bailing, you’ve got to wonder who’s left to buy once rates bite harder next quarter.
So what do we do? Don’t chase the tail end of moves—UNI’s upside will remain capped (Ambcrypto.com) and Dogecoin’s tweet-driven spikes are a trap. Recalibrate your sizing, keep stops tight around catalysts, and lean into names with visible event calendars—FDA decisions, CPI prints, or ETF approvals. That’s how you stay ahead of headline whiplash, not reacting but driving the trade narrative.
📈 Breaking Financial News
ETH open interest falls to 3-year low: What does it mean for Ether price?
Traders say Ether’s declining open interest and futures funding rates could set the groundwork for a significant short squeeze on bearish leveraged positions and a rally to $2,500.
5 Best Artificial Intelligence Stocks to Buy in February – The Motley Fool
5 Best Artificial Intelligence Stocks to Buy in FebruaryThe Motley Fool Top AI Stocks With Short Squeeze PotentialSeeking Alpha 3 Monster Stocks to Hold for the Next 3 YearsYahoo Finance As Tech Stocks Churn, Nvidia and Other Semiconductor Plays Look CheapMor…
Roku stock surges on earnings beat, record quarter for premium subscriptions
Roku executives said in a shareholder letter that it marked “our biggest quarter ever” for net adds to premium subscriptions.
Analyzing why UNI’s upside will remain capped despite ETF, BUIDL updates
The price reaction after the BUIDL integration news was instant, but short-lived.
Could PEPE repeat its April 2024 rally? THESE metrics say yes
Is PEPE setting up textbook a bear trap?
White House Insider Buck Sexton: “Trump's Next Move Will Shock the World”
dramatically increase U.S. power… and trigger a massive American market boom the likes of which we haven't seen in 75 years. Get the details here now.
🔍 Market Analysis & Insights
This TSX top gainer’s 25% leap prompts TD analyst to predict ‘upward financial revisions’ this year
The Week in Stocks: How to play Canada's Big Six banks as earnings loom, Veritas's dividend growth stock picks and target price hikes
Stock market today: Dow, S&P 500, Nasdaq gains fizzle to cap week of sharp losses as AI fears grow
Odds of a Fed rate cut in June nudge higher after ‘core' consumer inflation comes in at its lowest rate in four years.
Dogecoin: How traders can react to DOGE’s possible $0.10 move
Traders should not be looking to go long, though a price bounce appeared likely.
Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
WATERTOWN, Mass., Feb. 13, 2026 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, annou…
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm…
White House Insider Buck Sexton: “Trump's Next Move Will Shock the World”
dramatically increase U.S. power… and trigger a massive American market boom the likes of which we haven't seen in 75 years. Get the details here now.
💰 Investment Opportunities
Bitcoin bulls blitz $69K as retail traders pressure short positioning
Bitcoin reclaims the $69,000 level as retail investor-sized wallets accumulate $613 million of spot BTC in February. Will whales join the party and help turn $70,000 to support?
‘Great news’: Inflation ‘unexpectedly’ ratchets down to 2.4%, closer to Federal Reserve target
Gasoline prices down 7.5% over a year
Bitcoin $72K target possible if V-shaped recovery pattern completes
Bitcoin’s post-CPI rally above $69,000 could help complete the V-shaped recovery chart pattern and also confirm that $60,000 was the sell-off bottom.
XRP’s Funding Rate Just Hit a 10-Month Low—The Last Time This Happened XRP Price Rallied
XRP’s (CRYPTO: XRP) funding rate on Binance dropped to -0.028%, a 10-month low. A funding this negative means the selling side is crowded—almost everyone is …
Q3 Results Today Highlights: NBCC (India), IPCA Lab, NLC Industries Q3 profit up, Alkem Lab shares slump, Rategain & Blue Jet profit fall
Q3 Results Today, 13th Feb 2026 Highlights: Find all the latest Q3 results 2026 updates of Torrent Pharmaceuticals, GMR Airports, Siemens Energy India, Info Edge India, Alkem Laboratories, Fortis Healthcare, Narayana Hrudayalaya, Ipca Laboratories, ITI, NBCC …
The Elon Musk “Mystery Metal” That Could Break China's Grip
quietly engineered by Elon Musk… could end that crisis forever. And one tiny company is sitting at the center of it all. Musk is expected to make an announcement any day now. See more about this secret project here.